TMC NEWS

TMCNET eNEWSLETTER SIGNUP

ResMed Elects Harjit Gill to Its Board of Directors

ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical
devices and out-of-hospital software-as-a-service business solutions,
today announced it has elected experienced consumer and healthcare
executive Harjit Gill to its Board of Directors.

Ms. Gill was elected by shareholders at its annual shareholder meeting
last week in Sydney, Australia. Also, announced at that meeting, Gary W.
Pace has retired from ResMed's board after serving on it since July
1994. Ms. Gill's appointment and Dr. Pace's retirement both took effect
Thursday, November 15.

Ms. Gill has more than 25 years' experience in health and consumer
technology products as an executive, investor and regional business
leader spanning Asia, Europe and the Middle East. From 1990 to 2015, she
worked for Ryal Philips (News - Alert) as executive vice president and CEO for Philips
ASEAN & Pacific, overseeing Healthcare/Lighting and Consumer Lifestyle
Products; senior vice president of International Sales; vice president
of Asia for Philips Consumer Lifestyle Products; and various other
senior roles in Philips Consumer Electronics businesses in the
Netherlands, Hong Kong, Dubai and Singapore. From 2015 to 2016, she
served as chief operations and marketing officer for HTC (News - Alert), Taiwan. Since
2016, she has been advisor to Delmedica Investments, a Singapore-based
company focused on respiratory health and inventors of the X-Halo breath
thermometer.

Ms. Gill is also a board director for Apollo Education and Training, a
private company providing English teaching in Vietnam, and has held
various leadership roles at the Singapore chapter of YPO, which provides
growth and networking opportunities to CEOs worldwide.

"I'm very excited to welcome Harjit Gill to ResMed's Board," said ResMed
Founder and Board Chairman Peter Farrell. "ResMed will greatly benefit
from her vast experience, not only in healthcare and consumer
technology, but across the many global regions where ResMed continues to
expand its reach.

"I'd also like to thank Dr. Gary Pace for his valuable and effective
guidance to ResMed during his 24 years of service as a director," said
Farrell, "including during the period of ResMed's important
transformation from medical device company to global leader in connected
medical devices and out-of-hospital software."

About ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company
with more than 6 million cloud-connected devices for daily remote
patient monitoring, changes lives with every breath. Its award-winning
devices and software solutions help treat and manage sleep apnea,
chronic obstructive pulmonary disease and other respiratory conditions.
Its 6,000-member team strives to improve patients' quality of life,
reduce the impact of chronic disease and save healthcare costs in more
than 120 countries. ResMed.com